vs

Side-by-side financial comparison of CoStar Group (CSGP) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $899.9M, roughly 1.4× CoStar Group). Dexcom runs the higher net margin — 21.2% vs 5.2%, a 16.1% gap on every dollar of revenue. On growth, CoStar Group posted the faster year-over-year revenue change (26.9% vs 21.6%). Over the past eight quarters, CoStar Group's revenue compounded faster (17.1% CAGR vs 12.0%).

CoStar Group, Inc. is an American provider of information, analytics, and marketing services to the commercial property industry in North America and Europe. Founded in 1987 by Andrew C. Florance and based in Arlington, Virginia, the company operates the CoStar online database and news website and several online marketplaces, including Apartments.com and Homes.com.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CSGP vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.4× larger
DXCM
$1.3B
$899.9M
CSGP
Growing faster (revenue YoY)
CSGP
CSGP
+5.3% gap
CSGP
26.9%
21.6%
DXCM
Higher net margin
DXCM
DXCM
16.1% more per $
DXCM
21.2%
5.2%
CSGP
Faster 2-yr revenue CAGR
CSGP
CSGP
Annualised
CSGP
17.1%
12.0%
DXCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CSGP
CSGP
DXCM
DXCM
Revenue
$899.9M
$1.3B
Net Profit
$46.5M
$267.3M
Gross Margin
78.6%
62.9%
Operating Margin
5.5%
25.6%
Net Margin
5.2%
21.2%
Revenue YoY
26.9%
21.6%
Net Profit YoY
-22.2%
153.6%
EPS (diluted)
$0.12
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSGP
CSGP
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$899.9M
$1.3B
Q3 25
$833.6M
$1.2B
Q2 25
$781.3M
$1.2B
Q1 25
$732.2M
$1.0B
Q4 24
$709.4M
$1.1B
Q3 24
$692.6M
$994.2M
Q2 24
$677.8M
$1.0B
Net Profit
CSGP
CSGP
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$46.5M
$267.3M
Q3 25
$-30.9M
$283.8M
Q2 25
$6.2M
$179.8M
Q1 25
$-14.8M
$105.4M
Q4 24
$59.8M
$151.7M
Q3 24
$53.0M
$134.6M
Q2 24
$19.2M
$143.5M
Gross Margin
CSGP
CSGP
DXCM
DXCM
Q1 26
62.9%
Q4 25
78.6%
62.9%
Q3 25
79.3%
60.5%
Q2 25
78.5%
59.5%
Q1 25
79.1%
56.9%
Q4 24
80.1%
58.9%
Q3 24
79.7%
59.7%
Q2 24
80.0%
62.4%
Operating Margin
CSGP
CSGP
DXCM
DXCM
Q1 26
25.6%
Q4 25
5.5%
25.6%
Q3 25
-6.1%
20.1%
Q2 25
-3.5%
18.4%
Q1 25
-5.8%
12.9%
Q4 24
5.6%
17.0%
Q3 24
3.4%
15.3%
Q2 24
-2.4%
15.7%
Net Margin
CSGP
CSGP
DXCM
DXCM
Q1 26
21.2%
Q4 25
5.2%
21.2%
Q3 25
-3.7%
23.5%
Q2 25
0.8%
15.5%
Q1 25
-2.0%
10.2%
Q4 24
8.4%
13.6%
Q3 24
7.7%
13.5%
Q2 24
2.8%
14.3%
EPS (diluted)
CSGP
CSGP
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.12
$0.67
Q3 25
$-0.07
$0.70
Q2 25
$0.01
$0.45
Q1 25
$-0.04
$0.27
Q4 24
$0.14
$0.37
Q3 24
$0.13
$0.34
Q2 24
$0.05
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSGP
CSGP
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$1.6B
$917.7M
Total DebtLower is stronger
$140.0M
Stockholders' EquityBook value
$8.3B
$2.7B
Total Assets
$10.5B
$6.3B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSGP
CSGP
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$1.6B
$917.7M
Q3 25
$1.9B
$1.8B
Q2 25
$3.6B
$1.2B
Q1 25
$3.7B
$904.9M
Q4 24
$4.7B
$606.1M
Q3 24
$621.2M
Q2 24
$939.2M
Total Debt
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
$140.0M
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
CSGP
CSGP
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$8.3B
$2.7B
Q3 25
$8.6B
$2.7B
Q2 25
$8.6B
$2.6B
Q1 25
$8.6B
$2.3B
Q4 24
$7.6B
$2.1B
Q3 24
$7.5B
$2.0B
Q2 24
$7.4B
$2.4B
Total Assets
CSGP
CSGP
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$10.5B
$6.3B
Q3 25
$10.8B
$7.5B
Q2 25
$10.5B
$7.3B
Q1 25
$10.4B
$6.8B
Q4 24
$9.3B
$6.5B
Q3 24
$9.1B
$6.4B
Q2 24
$9.1B
$6.8B
Debt / Equity
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
0.02×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSGP
CSGP
DXCM
DXCM
Operating Cash FlowLast quarter
$162.1M
Free Cash FlowOCF − Capex
$101.3M
FCF MarginFCF / Revenue
11.3%
Capex IntensityCapex / Revenue
6.8%
Cash ConversionOCF / Net Profit
3.49×
TTM Free Cash FlowTrailing 4 quarters
$123.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
$162.1M
$294.0M
Q3 25
$68.2M
$659.9M
Q2 25
$146.5M
$303.0M
Q1 25
$53.2M
$183.8M
Q4 24
$94.6M
$301.4M
Q3 24
$100.3M
$199.5M
Q2 24
$58.1M
$279.4M
Free Cash Flow
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
$101.3M
$192.1M
Q3 25
$-5.5M
$579.4M
Q2 25
$27.7M
$208.9M
Q1 25
$-500.0K
$96.8M
Q4 24
$25.2M
$176.8M
Q3 24
$40.2M
$88.3M
Q2 24
$-14.7M
$213.3M
FCF Margin
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
11.3%
15.3%
Q3 25
-0.7%
47.9%
Q2 25
3.5%
18.1%
Q1 25
-0.1%
9.3%
Q4 24
3.6%
15.9%
Q3 24
5.8%
8.9%
Q2 24
-2.2%
21.2%
Capex Intensity
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
6.8%
8.1%
Q3 25
8.8%
6.7%
Q2 25
15.2%
8.1%
Q1 25
7.3%
8.4%
Q4 24
9.8%
11.2%
Q3 24
8.7%
11.2%
Q2 24
10.7%
6.6%
Cash Conversion
CSGP
CSGP
DXCM
DXCM
Q1 26
Q4 25
3.49×
1.10×
Q3 25
2.33×
Q2 25
23.63×
1.69×
Q1 25
1.74×
Q4 24
1.58×
1.99×
Q3 24
1.89×
1.48×
Q2 24
3.03×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSGP
CSGP

Co Star$503.8M56%
Other$283.0M31%
Loop Net$94.7M11%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons